Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Alcohol ; 103: 9-17, 2022 09.
Article in English | MEDLINE | ID: mdl-35714863

ABSTRACT

Recent findings have shown a relationship between alcohol use disorders (AUD) and chronic pain. Preclinical models have demonstrated that chronic pain, including trigeminal nerve injury, increases ethanol consumption throughout extended administration periods. Nevertheless, it remains unclear whether chronic pain induces a greater susceptibility to developing AUD by altering motor control consumption regardless of the symptomatology of neuropathic pain, and whether sex influences this susceptibility. We used a former prolonged pain experience model induced by a constriction of the mental nerve (mNC) to answer this question. We analyzed ethanol consumption in a short-access protocol to reduce the post-ingestional effects and compared licking microstructure between groups. The constriction of the mental nerve induced evoked and spontaneous pain and reduction in the hedonic value of sucrose. The differences in alcohol consumption were not reflective of the former prolonged pain experience. Female mice showed a more efficient dynamic of consumption of alcohol, reflected in a long burst of licking and a less variable licking rate within a cluster.


Subject(s)
Alcoholism , Chronic Pain , Animals , Disease Models, Animal , Ethanol , Facial Pain , Female , Mice , Sucrose
2.
Arch Oral Biol ; 135: 105369, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35149328

ABSTRACT

OBJECTIVE: To evaluate the effects of mental nerve injury in the facial reactions elicited by mechanical stimulation of different intensities and detect and quantify spontaneous facial pain-like expressions during a period free of stimuli, as signs of evoked and spontaneous pain in a mouse model for neuropathic orofacial pain. DESIGN: We recorded mouse heads in a fixed position during a stimulus-free period and with mechanical stimulation with 3 different Von Frey filaments. We extracted the Histograms of Oriented Gradients of each frame of the video recordings to be compared with a prototypical pain-like facial expression. The similarity score was then used to register and quantify the percentage of spontaneous pain-like facial reactions and evaluate the increased similarity to the prototypical pain-like face evoked by mechanical stimuli. The assessments were made one day before and four days after a unilateral mental nerve compression. RESULTS: Our findings show that mental nerve injury promotes an increase in spontaneous facial pain-like expressions and reduced mechanical threshold, reflected in a higher similarity to our pain-like face prototype, regardless of the intensity of the stimuli applied. CONCLUSIONS: Machine vision encodes the facial expression associated with evoked and spontaneous pain after mental nerve injury for up to four days. Facial expression quantitatively reflects the increased mechanical sensitivity elicited by mental nerve injury. We also show that this technique can detect spontaneous pain-like responses from facial reactions. Artificial vision can be applied to evaluate signs of orofacial neuropathic pain to study the involved neural circuits.


Subject(s)
Hyperalgesia , Neuralgia , Animals , Disease Models, Animal , Facial Expression , Facial Pain , Mice , Rats , Rats, Sprague-Dawley
3.
Am J Gastroenterol ; 112(1): 120-131, 2017 01.
Article in English | MEDLINE | ID: mdl-27958281

ABSTRACT

OBJECTIVES: The aims of this study were to assess the risk of relapse after discontinuation of anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory bowel disease (IBD), to identify the factors associated with relapse, and to evaluate the overcome after retreatment with the same anti-TNF in those who relapsed. METHODS: This was a retrospective, observational, multicenter study. IBD patients who had been treated with anti-TNFs and in whom these drugs were discontinued after clinical remission was achieved were included. RESULTS: A total of 1,055 patients were included. The incidence rate of relapse was 19% and 17% per patient-year in Crohn's disease and ulcerative colitis patients, respectively. In both Crohn's disease and ulcerative colitis patients in deep remission, the incidence rate of relapse was 19% per patient-year. The treatment with adalimumab vs. infliximab (hazard ratio (HR)=1.29; 95% confidence interval (CI)=1.01-1.66), elective discontinuation of anti-TNFs (HR=1.90; 95% CI=1.07-3.37) or discontinuation because of adverse events (HR=2.33; 95% CI=1.27-2.02) vs. a top-down strategy, colonic localization (HR=1.51; 95% CI=1.13-2.02) vs. ileal, and stricturing behavior (HR=1.5; 95% CI=1.09-2.05) vs. inflammatory were associated with a higher risk of relapse in Crohn's disease patients, whereas treatment with immunomodulators after discontinuation (HR=0.67; 95% CI=0.51-0.87) and age (HR=0.98; 95% CI=0.97-0.99) were protective factors. None of the factors were predictive in ulcerative colitis patients. Retreatment of relapse with the same anti-TNF was effective (80% responded) and safe. CONCLUSIONS: The incidence rate of inflammatory bowel disease relapse after anti-TNF discontinuation is relevant. Some predictive factors of relapse after anti-TNF withdrawal have been identified. Retreatment with the same anti-TNF drug was effective and safe.


Subject(s)
Adalimumab/therapeutic use , Antirheumatic Agents/therapeutic use , Colitis, Ulcerative/drug therapy , Crohn Disease/drug therapy , Deprescriptions , Immunologic Factors/therapeutic use , Infliximab/therapeutic use , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Colitis, Ulcerative/physiopathology , Colon , Constriction, Pathologic , Crohn Disease/physiopathology , Disease Progression , Drug-Related Side Effects and Adverse Reactions , Female , Follow-Up Studies , Humans , Ileum , Incidence , Inflammatory Bowel Diseases/drug therapy , Male , Mesalamine/therapeutic use , Methotrexate/therapeutic use , Middle Aged , Proportional Hazards Models , Protective Factors , Recurrence , Remission Induction , Retreatment , Retrospective Studies , Risk Factors , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Young Adult
4.
Aliment Pharmacol Ther ; 45(2): 300-309, 2017 01.
Article in English | MEDLINE | ID: mdl-27868216

ABSTRACT

BACKGROUND: Conflicting results have been recently reported for the accuracy of the Endoscopic Reference Score (EREFS), an standardised endoscopic classification, to predict the histological activity of eosinophilic oesophagitis (EoE). AIM: To evaluate the accuracy of the EREFS to predict either histological or clinical activity of EoE. METHODS: Prospective multicentre study conducted in eight Spanish centres evaluating adult EoE patients, either naïve or after treatment. Symptoms were evaluated before upper endoscopy through the Dysphagia Symptom Score, whereas researchers scored the EREFS immediately after the endoscopic procedure, unaware of the histological outcome. RESULTS: One hundred and forty-five EoE patients undergoing 240 consecutive endoscopic procedures were included. Exudates (P = 0.03), furrows (P = 0.03) and a composite score of inflammatory signs (exudates, furrows and oedema) (P < 0.001) accurately predicted histological activity. Exudates were the only endoscopic sign showing a good correlation with histological outcome after therapy. Furrows and oedema persisted in 50% and 70% of patients despite histological remission. No endoscopic feature exceeded 70% accuracy to predict histological activity. Likewise, no endoscopic finding could adequately predict dysphagia severity. Crepe paper mucosa, diffuse exudates and severe rings correlated with higher symptom scores. CONCLUSIONS: Endoscopic findings assessed by the Endoscopic Reference Score did not correlate with histological or clinical disease activity in adult EoE patients. Only exudates correlated with peak eosinophil count and histological outcome, whereas furrows and oedema persisted in over half of patients despite histological remission.


Subject(s)
Eosinophilic Esophagitis/pathology , Gastroscopy , Adult , Deglutition Disorders/diagnosis , Deglutition Disorders/immunology , Deglutition Disorders/pathology , Eosinophilic Esophagitis/diagnosis , Eosinophilic Esophagitis/immunology , Eosinophils/immunology , Esophagus/immunology , Esophagus/pathology , Female , Humans , Leukocyte Count , Male , Middle Aged , Mucous Membrane/immunology , Mucous Membrane/pathology , Prospective Studies , Reference Values , Young Adult
5.
Aliment Pharmacol Ther ; 43(1): 3-15, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26510832

ABSTRACT

BACKGROUND: The recognition of eosinophilic oesophagitis (EoE) has risen sharply, but its current epidemiology is still under debate. AIM: To estimate accurately the prevalence and incidence rates of EoE, by a systematic review and meta-analysis. METHODS: MEDLINE, EMBASE and SCOPUS databases were searched for population-based studies on the epidemiology of EoE. Pooled incidence and prevalence rates, male:female and children:adult ratios, and geographical and temporal variations were calculated with random-effects models. RESULTS: The search yielded 1334 references; the final quantitative summary included 13 population-based studies from North America, Europe and Australia, with the results showing high heterogeneity. The pooled EoE incidence rate was 3.7/100 000 persons/year [95% confidence interval (CI): 1.7-6.5] and was higher for adults (7; 95% CI: 1-18.3) than for children (5.1; 95% CI: 1.5-10.9). The pooled prevalence of EoE was 22.7 cases/100 000 inhabitants (95% CI: 12.4-36), rising to 28.1 (95% CI: 13-49) when studies with a lower risk of bias were considered; prevalence was higher in adults than in children (43.4; 95% CI: 22.5-71.2 vs. 29.5; 95% CI: 17.5-44.7, respectively), and in American compared to European studies. A steady rise in EoE incidence and prevalence rates was observed upon comparison of studies conducted before and after 2008. No significant publication bias was found. CONCLUSIONS: Eosinophilic oesophagitis is an increasingly common diagnosis in North America and Europe. The population-based incidence and prevalence of eosinophilic oesophagitis vary widely across individual studies, probably due to variations in diagnosis and risk of bias of research. More prospective, large-scale, multicenter studies are needed to evaluate reported data.


Subject(s)
Eosinophilic Esophagitis/epidemiology , Age Distribution , Databases, Factual , Humans , Incidence , Prevalence , Prospective Studies , Research Design , Sex Distribution
10.
Eur J Clin Microbiol Infect Dis ; 27(6): 451-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18246375

ABSTRACT

Recently, the incidence of human mycobacterial infections due to species other than M. tuberculosis has increased worldwide. Since disease control depends on appropriate antimicrobial therapy, the precise identification of these species of clinical importance has become a major public health concern. Identification of mycobacteria has been hampered because of the lack of specific, rapid, and inexpensive methods. Therefore, we aimed at designing and validating a bacterial lysate-based polymerase chain reaction identification scheme. This scheme can classify clinical isolates into: (1) the genus Mycobacterium, (2) the M. tuberculosis complex, (3) the nontuberculous mycobacteria, and (4) the species M. avium, M. intracellulare, M. abscessus, M. chelonae, M. fortuitum and M. bovis of clinical importance, and M. gordonae, the most commonly encountered nonpathogenic species in clinical laboratories. By using M. fortuitum and M. avium lysates as models, the method sensitivity was determined to be 372 pg of DNA. In a blind parallel comparison between our approach and conventional biochemical tests, both assays correctly categorized 75 patient's mycobacterial isolates. However, our approach only required 4-9 h for categorization compared with at least 15 days by conventional tests. Furthermore, our methodology could also detect M. fortuitum and M. avium from liquid cultures, after only 2 and 6 days, respectively, of incubation. Our new identification scheme is therefore sensitive, specific, rapid, and economic. Additionally, it can help to provide proper treatment to patients, to control these diseases, and to improve our knowledge of the epidemiology of mycobacteriosis, all urgently needed, particularly in developing countries.


Subject(s)
Bacteria/genetics , Cell Extracts/genetics , Mycobacterium/pathogenicity , Sensitivity and Specificity , Bacterial Typing Techniques , Humans , Mycobacterium/classification , Mycobacterium/genetics , Mycobacterium/isolation & purification , Mycobacterium Infections/microbiology , Mycobacterium Infections/physiopathology , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/isolation & purification , Polymerase Chain Reaction/methods , Species Specificity
11.
Rev Neurol ; 40(7): 420-2, 2005.
Article in Spanish | MEDLINE | ID: mdl-15849676

ABSTRACT

INTRODUCTION: Parotiditis is a viral infection that produces a non-suppurative inflammation of the parotid glands, although it may affect other salivary glands, the testicles, meninges and the pancreas. Clinical meningitis appears in 1-10% of cases, normally between the 4th and the 10th day after infection of the parotid glands. In this study, we analyse the clinical and analytic characteristics of the patients admitted to our Neurology Department over the last 12 years. CASE REPORTS: A retrospective study was conducted by analysing the hospital discharge reports. The eligibility criterion was the existence of an acute meningeal syndrome linked to the presence of positive IgM titres for the parotiditis virus. In all, 13 cases were found, with a mean age of 16.5 years, and most of them were males (92.3%). Parotiditis preceded meningitis in all our patients with an average of 8.3 days, while orchiepididymitis, when it occurred, appeared at the same time or after meningitis. Analysis of the cerebrospinal fluid showed a lymphocyte profile with glycorrhachia above 40%, except in two cases that showed a non-persistent neutrophilic profile. There was a transient 30.7% reduction in prothrombin time in the patients. No sequelae were observed. CONCLUSIONS: Vaccination campaigns have drastically reduced the number of cases of meningitis due to this germ since the second half of the 90s. This virus must be borne in mind in cases of meningitis in young males who come from underdeveloped countries.


Subject(s)
Meningitis/epidemiology , Mumps/epidemiology , Adolescent , Catchment Area, Health , Epididymitis/epidemiology , Epididymitis/etiology , Female , Humans , Male , Meningitis/cerebrospinal fluid , Meningitis/prevention & control , Mumps/complications , Mumps Vaccine , Neurology , Orchitis/epidemiology , Orchitis/etiology , Parotitis/epidemiology , Parotitis/prevention & control , Parotitis/virology , Retrospective Studies , Spain/epidemiology
12.
Rev. neurol. (Ed. impr.) ; 40(7): 420-422, 1 abr., 2005. ilus, tab
Article in Es | IBECS | ID: ibc-037057

ABSTRACT

Introducción. La parotiditis es una infección vírica que produce inflamación no supurada de las parótidas, aunque puede afectar a otras glándulas salivares, los testículos, las meninges y el páncreas. La meningitis clínica aparece en el 1-10% de los casos, normalmente entre el 4.º y el 10.º día de la inflamación parotídea. Se analizan las características clínicas y analíticas de los pacientes con esta meningitis ingresados en nuestro Servicio de Neurología en los últimos 12 años. Casos clínicos. Se ha realizado un estudio retrospectivo analizando los informes de alta. El criterio de inclusión es la existencia de un síndrome meníngeo agudo asociado a la presencia de una valoración positiva IgM frente al virus de la parotiditis. Se han encontrado 13 casos con una media de edad de 16,5 años; la mayoría son varones (92,3%). La parotiditis precede a la meningitis en todos nuestros pacientes en 8,3 días de media, mientras que la orquiepididimitis, cuando aparece, lo hace a la vez que la meningitis o después. El análisis del líquido cefalorraquídeo muestra un perfil linfocitario con glucorraquia por encima del 40%, excepto en dos casos que presentan un perfil neutrofílico no persistente. Existe un descenso transitorio del tiempo de protrombina en el 30,7% de los pacientes. No hemos encontrado secuelas. Conclusiones. Las campañas de vacunación han producido una drástica reducción de las meningitis por este germen a partir de la segunda mitad de los años 90. Se debe tener en cuenta este virus en los casos de meningitis en varones jóvenes procedentes de países subdesarrollados


Introduction. Parotiditis is a viral infection that produces a non-suppurative inflammation of the parotid glands, although it may affect other salivary glands, the testicles, meninges and the pancreas. Clinical meningitis appears in 1-10% of cases, normally between the 4th and the 10th day after infection of the parotid glands. In this study, we analyse the clinical and analytic characteristics of the patients admitted to our Neurology Department over the last 12 years. Case reports. A retrospective study was conducted by analysing the hospital discharge reports. The eligibility criterion was the existence of an acute meningeal syndrome linked to the presence of positive IgM titres for the parotiditis virus. In all, 13 cases were found, with a mean age of 16.5 years, and most of them were males (92.3%). Parotiditis preceded meningitis in all our patients with an average of 8.3 days, while orchiepididymitis, when it occurred, appeared at the same time or after meningitis. Analysis of the cerebrospinal fluid showed a lymphocyte profile with glycorrhachia above 40%, except in two cases that showed a non-persistent neutrophilic profile. There was a transient 30.7% reduction in prothrombin time in the patients. No sequelae were observed. Conclusions. Vaccination campaigns have drastically reduced the number of cases of meningitis due to this germ since the second half of the 90s. This virus must be borne in mind in cases of meningitis in young males who come from underdeveloped countries


Subject(s)
Humans , Meningitis/epidemiology , Mumps/epidemiology , Epididymitis/epidemiology , Epididymitis/etiology , Meningitis/cerebrospinal fluid , Meningitis/prevention & control , Mumps/complications , Mumps Vaccine , Neurology , Orchitis/epidemiology , Orchitis/etiology , Parotitis/epidemiology , Parotitis/prevention & control , Parotitis/virology , Retrospective Studies , Spain/epidemiology , Catchment Area, Health
13.
Prog. obstet. ginecol. (Ed. impr.) ; 44(12): 552-555, dic. 2001.
Article in Es | IBECS | ID: ibc-4579

ABSTRACT

La asociación de feocromocitoma y gestación es rara; su diagnóstico es difícil dada su similitud con la preeclampsia. El pronóstico maternofetal es determinado por el diagnóstico precoz y el manejo multidisciplinario. El diagnóstico se establece por la elevación de catecolaminas en orina de 24 h y las técnicas de imagen. La extirpación del tumor, previo bloqueo adrenérgico, se realiza en función de la edad gestacional antes o después del parto.Así, se reduce de forma considerable la mortalidad maternofetal, que es muy alta cuando se desconoce el diagnóstico (AU)


No disponible


Subject(s)
Adult , Pregnancy , Female , Humans , Pheochromocytoma/complications , Pheochromocytoma/diagnosis , Pregnancy Complications/diagnosis , Pregnancy Complications, Neoplastic/diagnosis , Pregnancy Trimester, Third , Hypertension/complications , Hypertension/diagnosis , Thoracotomy/methods , Nitroprusside/administration & dosage , Nitroprusside/therapeutic use , Arrhythmias, Cardiac/complications , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/diagnosis , Maternal and Child Health , Pregnancy Complications, Neoplastic/physiopathology , Catecholamines , Catecholamines/urine , Maternal Mortality , Pregnancy Complications, Cardiovascular/diagnosis
14.
Cienc. ginecol ; 4(6): 276-282, nov. 2000. ilus, tab
Article in Es | IBECS | ID: ibc-11452

ABSTRACT

El tamoxifeno es la terapia coadyuvante prescrita con más frecuencia en mujeres con cáncer de mama. Objetivo: valoración de los hallazgos histeroscópicos en mujeres con cáncer de mama en tratamiento con tamoxifeno durante un tiempo superior a seis meses, cuando se ha encontrado patología endometrial en la ecografía transvaginal de screening o la paciente ha presentado síntomas. Diseño del estudio: estudio retrospectivo de 73 pacientes con cáncer de mama en tratamiento con tamoxifeno sometidas a una histeroscopia diagnóstica Resultados: La media de edad de las pacientes fue de 62,28 años; de éstas el 89 por ciento fueron postmenopáusicas. La principal indicación para realizar la histeroscopia fue la sospecha ecográfica de patología endometrial (82 por ciento), seguido de la metrorragia postmenopáusica (13,7 por ciento).El hallazgo ecográfico más frecuente fue la presencia de un endometrio engrosado (75,3 por ciento). Los hallazgos histeroscópicos por orden de frecuencia fueron: histeroscopia normal, pólipos, hiperplasia quistica y atrofia endometrial. No hubo ningún caso de adenocarcinoma (AU)


Subject(s)
Female , Middle Aged , Humans , Hysteroscopy , Anticarcinogenic Agents/therapeutic use , Endometrium/physiopathology , Tamoxifen/therapeutic use , Breast Neoplasms/drug therapy , Endometrium , Endometrium , Retrospective Studies
15.
Cienc. ginecol ; 4(2): 96-98, mar. 2000. ilus
Article in Es | IBECS | ID: ibc-11430

ABSTRACT

Se presenta el caso de una masa anexial asociada a gestación. La actitud ante este hallazgo depende de la sospecha de benignidad-malignidad y del tamaño de la tumoración. En nuestro caso el tamaño mayor a 8 cm de la tumoración obligaba a una laparotomía por la posibilidad de complicaciones posteriores.El diagnóstico ecográfico de teratoma gigante en el primer trimestre permitió esperar al segundo trimestre de gestación cuando la pérdida fetal es prácticamente nula.La evolución de la gestación tras la laparotomía fue satisfactoria siendo un embarazo y parto normales (AU)


Subject(s)
Adult , Female , Humans , Teratoma , Pregnancy Complications, Neoplastic , Teratoma/surgery , Pregnancy Complications, Neoplastic/surgery , Pregnancy Trimester, First , Pregnancy Trimester, Second , Laparotomy
16.
Rev Esp Salud Publica ; 72(1): 43-51, 1998.
Article in Spanish | MEDLINE | ID: mdl-9477715

ABSTRACT

BACKGROUND: Spanish prisons have a high number of inmates whose behaviour puts them at risk of being infected by hepatitis C virus (HCV). The object of this study was to establish the prevalence of this infection and its associated factors in the prison population of the north-east of Spain. METHODS: Inmates in seven prisons in the north-east of Spain were studied. Socio-demographic and prison variables were gathered, as well as risk factors for infection by HCV. Antibodies against HCV were determined (EIA and INNO-LIA HCV III), Hepatitis B virus (VHB) (EIA), and human immunodeficiency virus (HIV) (EIA and Western-Blott). The analysis of associated factors was based on logistic regression. RESULTS: Of the total number of inmates studied, 47.9% presented HCV antibodies. There was greater prevalence in the case of the following: UDVP (89.6%); those who shared needles (94%); those infected by HIV (92.7%); carriers of Australia antigen (65.1%) and antibodies to the HBV core antigen (79.8%); those who had been in prison before (60.9%); unmarried men (54.8%); gypsies (52%); unqualified workers (50.4%); those who had no basic school qualifications (50.9%); those with tattoos (66.7%); and those with a background of self-inflicted injuries (79.3%). In the logistic regression analysis the variables associated to infection by HCV were: UDVP (OR = 33.3; I.C. 95% = 25-50), HBcAc (+) (OR = 4.1; I.C. 95% = 1.1-5.3), age (OR = 0.98; I.C. 95% = 0.96-1.00), months in prison (OR = 1.011; I.C. 95% = 1.004-1.019) and a background of previous prison sentences (OR = 2.3; I.C. 95% = 1.5-3.6). CONCLUSIONS: The prevalence of infection by HCV in prison inmates is very high. It is therefore recommended that preventive measures be increased (harm reduction programmes) and that clinical and analysis protocols be drawn up for those infected and for treatment in cases of chronic active hepatitis in order to control this serious public health problem.


Subject(s)
Hepatitis C/epidemiology , Prisoners , Prisons , Adult , Female , Hepatitis C/blood , Hepatitis C/immunology , Hepatitis C Antibodies/blood , Humans , Male , Prevalence , Seroepidemiologic Studies , Spain
SELECTION OF CITATIONS
SEARCH DETAIL
...